Details.
On-demand online webinar for professionals involved in early cardiometabolic drug development. Explore how to design early development programmes that generate meaningful pharmacodynamic evidence alongside safety and pharmacokinetics, including selecting endpoints aligned to cardiometabolic comorbidities, involving patient populations earlier, and integrating advanced metabolic, biomarker, and functional assessments. The panel features experts from hVIVO and University Hospitals Quiron Salud Madrid.